Skip to main content
. 2017 Sep 8;8(56):95412–95424. doi: 10.18632/oncotarget.20728

Figure 1. HER-3 expression in human metastatic melanoma.

Figure 1

(A) (160X original magnification) and (B) (250X original magnification): concomitant lymph node metastases. (C) (250X original magnification) and (D) (250X original magnification): metachronous lymph node metastases. Tissues were stained for HER-3 expression using MP-RM-1 antibody. Black arrows indicate MP-RM-1 membrane reactivity.